• Traceable against the WHO 2nd International Standard for Human IgE 75/502
  • Well correlated to the market leader
  • Continuously growing panel
  • Fully automated

An automated assay for the quantitative determination of Specific IgE in human serum on the IDS System. The results are to be used as an aid in the diagnosis and management of allergic disorders in conjunction with other clinical findings. The presence of allergen-specific IgE antibodies in serum is referred to as sensitisation and is an important risk factor for allergic reactions upon re-exposure to the allergen (1).

Moulds are primary and opportunistic pathogens but also major allergenic sources. Fungal sensitisation is relevant in the development of allergic rhinitis and severity of asthma (2). Aspergillus fumigatus is the causative agent involved in allergic bronchopulmonary aspergillosis, an inflammatory response in the lung (3).

  1. Hamilton RG. Allergic sensitization is a key risk factor for but not synonymous with allergic disease. J Allergy Clin Immunol. 2014 Aug;134(2):360-1
  2. Kespohl S, Raulf M. Mould allergens: Where do we stand with molecular allergy diagnostics? Part 13 of the series Molecular Allergology. Allergo J Int 2014; 23: 120–5
  3. Matricardi PM,  Kleine-Tebbe  J,  Hoffmann  HJ,  Valenta  R,  Hilger  C,  et  EAACI  Molecular  Allergology  User’s  Guide.  Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250
  • IDS Total IgE / Specific IgE Reagent Kit
  • IDS Total IgE Control Set
  • IDS Positive and Negative Specific IgE Controls